Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase
Takeshi
T
Iwase
Chie
C
D000368:Aged; D001764:Blepharospasm / Q000188:drug therapy; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D003680:Deglutition Disorders / Q000139:chemically induced*; D004401:Dysarthria / Q000139:chemically induced*; D005143:Eyelids / Q000187:drug effects; D005260:Female; D006801:Humans; D018908:Muscle Weakness / Q000139:chemically induced*; D009157:Myasthenia Gravis / Q000175:diagnosis*; D009465:Neuromuscular Agents / Q000009:adverse effects*; D014103:Torticollis / Q000188:drug therapy
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A